1981 related articles for article (PubMed ID: 17157294)
1. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
[TBL] [Abstract][Full Text] [Related]
2. Effect of nitrovasodilators and inhibitors of nitric oxide synthase on ischaemic and reperfusion function of rat isolated hearts.
du Toit EF; McCarthy J; Miyashiro J; Opie LH; Brunner F
Br J Pharmacol; 1998 Mar; 123(6):1159-67. PubMed ID: 9559900
[TBL] [Abstract][Full Text] [Related]
3. Deletion of endothelial nitric oxide synthase exacerbates myocardial stunning in an isolated mouse heart model.
Hannan RL; John MC; Kouretas PC; Hack BD; Matherne GP; Laubach VE
J Surg Res; 2000 Sep; 93(1):127-32. PubMed ID: 10945953
[TBL] [Abstract][Full Text] [Related]
4. Role of myocardial nitric oxide in diabetic ischemia-reperfusion dysfunction: studies in mice with myocyte-specific overexpression of endothelial nitric-oxide synthase.
Pozo-Navas B; Stessel H; Wölkart G; Brunner F
J Pharmacol Exp Ther; 2006 Nov; 319(2):729-38. PubMed ID: 16857730
[TBL] [Abstract][Full Text] [Related]
5. Ischemic preconditioning: infarct size is a more reliable endpoint than functional recovery.
Lochner A; Genade S; Moolman JA
Basic Res Cardiol; 2003 Sep; 98(5):337-46. PubMed ID: 12955407
[TBL] [Abstract][Full Text] [Related]
6. Contribution of NO to ischemia-reperfusion injury in the saline-perfused heart: a study in endothelial NO synthase knockout mice.
Flögel U; Decking UK; Gödecke A; Schrader J
J Mol Cell Cardiol; 1999 Apr; 31(4):827-36. PubMed ID: 10329210
[TBL] [Abstract][Full Text] [Related]
7. Infarct size and nitric oxide synthase in murine myocardium.
Sumeray MS; Rees DD; Yellon DM
J Mol Cell Cardiol; 2000 Jan; 32(1):35-42. PubMed ID: 10652188
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of the nitric oxide-cGMP pathway exacerbates postischaemic heart injury in stroke-prone hypertensive rats.
Itoh T; Haruna M; Abe K
Exp Physiol; 2007 Jan; 92(1):147-59. PubMed ID: 17030559
[TBL] [Abstract][Full Text] [Related]
9. Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia.
House SL; Bolte C; Zhou M; Doetschman T; Klevitsky R; Newman G; Schultz Jel J
Circulation; 2003 Dec; 108(25):3140-8. PubMed ID: 14656920
[TBL] [Abstract][Full Text] [Related]
10. Cardiomyocyte-specific overexpression of NO synthase-3 protects against myocardial ischemia-reperfusion injury.
Elrod JW; Greer JJ; Bryan NS; Langston W; Szot JF; Gebregzlabher H; Janssens S; Feelisch M; Lefer DJ
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1517-23. PubMed ID: 16645153
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
[TBL] [Abstract][Full Text] [Related]
12. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Liu YN; Zhou ZM; Chen P
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
[TBL] [Abstract][Full Text] [Related]
13. Kinases and phosphatases in ischaemic preconditioning: a re-evaluation.
Fan WJ; van Vuuren D; Genade S; Lochner A
Basic Res Cardiol; 2010 Jul; 105(4):495-511. PubMed ID: 20127248
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
[TBL] [Abstract][Full Text] [Related]
15. Post-conditioning reduces infarct size in the isolated rat heart: role of coronary flow and pressure and the nitric oxide/cGMP pathway.
Penna C; Cappello S; Mancardi D; Raimondo S; Rastaldo R; Gattullo D; Losano G; Pagliaro P
Basic Res Cardiol; 2006 Mar; 101(2):168-79. PubMed ID: 16132172
[TBL] [Abstract][Full Text] [Related]
16. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO
Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase.
Burger D; Lei M; Geoghegan-Morphet N; Lu X; Xenocostas A; Feng Q
Cardiovasc Res; 2006 Oct; 72(1):51-9. PubMed ID: 16904088
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of histidine-rich Ca-binding protein protects against ischemia/reperfusion-induced cardiac injury.
Zhou X; Fan GC; Ren X; Waggoner JR; Gregory KN; Chen G; Jones WK; Kranias EG
Cardiovasc Res; 2007 Aug; 75(3):487-97. PubMed ID: 17499229
[TBL] [Abstract][Full Text] [Related]
19. Microvascular preconditioning is not detectable by corrosion casting in the isolated perfused rat heart after 30 minutes of ischaemia.
Arangannal A; McGarrity A; Wheatley DJ; Belcher PR
Scand Cardiovasc J; 2008 Feb; 42(1):90-5. PubMed ID: 18273729
[TBL] [Abstract][Full Text] [Related]
20. Myocardial release of nitric oxide during ischaemia and reperfusion: effects of L-arginine and hypercholesterolaemia.
Prasan AM; McCarron HC; Zhang Y; Jeremy RW
Heart Lung Circ; 2007 Aug; 16(4):274-81. PubMed ID: 17420156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]